KLRK1 and neoplasm: Put together, these reports strongly suggest that tumor cells are able to release NKG2DLs-expressing exosomes that then are able to interact with the NKG2D receptors present on the surface of NK cells, as well as with CD8+ T cells, causing its internalization, hindering the NKG2D-dependent activation of these cells and providing immune escape to tumor cells.